Skip to content
    Columbus Venture Partners logo

    Columbus Venture Partners

    Valencia, SpainFounded 2016
    columbusvp.com/enLinkedIn
    Biotech & Life SciencesHealthcare

    Columbus Venture Partners is a Spanish venture capital firm specializing in biotechnology and life sciences, investing in therapeutic and industrial biotech platforms. Founded in 2016 in Valencia, it combines therapeutic seed funding with infrastructure creation across Europe and the U.S.

    42% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (3 deals in the last 12 months vs 9 prior). Average disclosed round size is $37.9M (across 17 rounds with reported amounts).

    Find people at Columbus Venture Partners on Goldilocks AI

    Portfolio

    31

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    3

    Team

    DT

    Damia Tormo

    General Partner

    JG

    Javier García

    General Partner

    GR

    Guillermo R.

    Operational Partner

    JF

    Javier Fernández

    Operating Partner

    JM

    Jose Mesa

    Partner

    MV

    Marcos Vasquez

    Investment Analyst

    RF

    Reese Fields

    Venture Capital

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    38 investments
    CompanyRoundAmountDate
    Ona Therapeutics logoOna TherapeuticsSeries B$86.6MJun 2026
    Accipiter Biosciences logoAccipiter BiosciencesSeed$12.7MNov 2025
    Accipiter logoAccipiterSeed$12.7MNov 2025
    Arthex Biotech logoArthex BiotechSeries B$87MSep 2025
    AARTHEX BIOTECH S.L.Series B$87MSep 2025
    INTEGRA THERAPEUTICS logoINTEGRA THERAPEUTICSPre-Seed—Sep 2025
    Deepull logoDeepullSeries C—Apr 2025
    DDEEPULL DIAGNOSTICS, S.L.Series C—Apr 2025
    LLutris PharmaUnknown$30MJan 2025
    Accipiter logoAccipiterSeed$12.7MJan 2025
    Tolerance Bio logoTolerance BioSeed$20.2MDec 2024
    Tolerance Bio logoTolerance BioSeed$17.2MOct 2024
    Tolerance logoToleranceSeed$17.2MOct 2024
    Artax Biopharma logoArtax BiopharmaUnknown$8MAug 2024
    SSyngoi TechnologiesSeries B—Jun 2024
    Multiverse Computing logoMultiverse ComputingSeries A—Mar 2024
    Curve Therapeutics logoCurve TherapeuticsSeries A$40.5MFeb 2024
    Fingercheck logoFingercheckGrowth$115MJan 2024
    SSyngoi TechnologiesSeries B—Jan 2024
    CCocoon BioscienceGrowth—Mar 2023
    Jurata Thin Film logoJurata Thin FilmSeed$4.9MNov 2022
    JJurataSeed$4.9MNov 2022
    IIntegra TherapeuticsSeed—Mar 2022
    NeRRe Therapeutics logoNeRRe TherapeuticsUnknown—Jul 2021
    Algenex logoAlgenexSeries C—Sep 2020
    Page 1 of 2

    Top Co-Investors

    Ysios Capital8 shared
    Kurma Partners6 shared
    AdBio partners5 shared
    Takeda Ventures, Inc.5 shared
    Caixa Capital Risc5 shared
    Bpifrance4 shared
    European Innovation Council (EIC)4 shared
    Roche Venture Fund4 shared
    Asabys Partners4 shared
    CDTI4 shared
    Argonautic Ventures3 shared
    HealthCap3 shared
    Novartis Venture Fund3 shared
    Forbion3 shared
    Ben Franklin Technology Partners3 shared
    Hadean Ventures2 shared
    WRF Capital2 shared
    Flying Fish2 shared
    Alexandria Venture Investments2 shared
    Washington Research Foundation2 shared

    Last updated: 20 October 2026